MedPath

Japan COVID-19 Study of the psychosocial impacts of the postponement/cancellation of reproductive medicine

Not Applicable
Conditions
Infertility or fertility preservation for medical reasons.
Registration Number
JPRN-UMIN000041387
Lead Sponsor
Division of The International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center
Brief Summary

As a result, 59.6% of the patients continued their fertility treatments in April and May 2020, whereas 27.3% of the patients cancelled the consultation due to COVID-19. Of those who had treatment canceled, 80.5% found it to be upsetting and 5.7% found it not upsetting. About 60% had poor mental health regardless of whether they continued or cancelled their treatment in April or May 2020. About 60% or more patients took appropriate stress coping behavior.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
911
Inclusion Criteria

Not provided

Exclusion Criteria

Couples who finish treating reproductive medicine due to pregnancy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath